Bio goes abroad

While everyone is focused on the IT jobs that have gone offshore, it’s important to realize that it will happen in other economic areas such as biotech and drug development. This article mentions companies in Australia and New Zeland that are eager to do clinical trials in those countries. It’s cheaper there.

Shipping jobs overseas, especially to places where there are well-trained, English-speaking workers, is commonplace in Silicon Valley. It’s still relatively new in the biotech sector, but it’s coming and in some unexpected places. …
A large part of the reason is cost. Medical studies, required by the FDA for new drugs and other products, are expensive and Novotech claims it can save its customers 35 percent to 40 percent without compromising the quality of the study.